CERebrolysin In CADASIL
Clinical trial NCT05755997 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05755997
- Sponsor
- Ever Neuro Pharma GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-29
- Primary completion
- 2026-03-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.